Tejnaksh Healthcare Limited (BOM:539428)

Tejnaksh Healthcare Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	120.22	128.97	121.75	117.27	126.76	119.6
Other Revenue	1.24	1.24	0.81	1.42	0.64	-
Revenue	121.46	130.21	122.56	118.69	127.4	119.6
Revenue Growth (YoY)	-3.84%	6.24%	3.26%	-6.84%	6.52%	-31.11%
Cost of Revenue	38.56	35.87	29.46	31.25	30.4	24.4
Gross Profit	82.91	94.34	93.1	87.44	97	95.2
Selling, General & Admin	0.22	0.22	0.58	0.34	0.21	0.12
Other Operating Expenses	49.2	52.13	55.49	48.81	48.17	57.9
Operating Expenses	60.24	61.45	65.12	57.89	55.03	64.83
Operating Income	22.67	32.89	27.98	29.55	41.97	30.37
Interest Expense	-2.39	-3.76	-6.41	-6.08	-4.02	-4.86
Interest & Investment Income	1.5	1.5	2.05	1.33	0.62	0.56
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.04	0.01	-	-
Other Non Operating Income (Expenses)	1.59	1.31	0.17	0.31	-0.52	0.66
EBT Excluding Unusual Items	23.35	31.91	23.75	25.13	38.06	26.74
Gain (Loss) on Sale of Assets	-	-	-	-	-0.45	-0.06
Pretax Income	23.35	31.91	23.75	25.13	37.61	26.68
Income Tax Expense	8.08	9.61	6.11	7.21	9.5	5.99
Earnings From Continuing Operations	15.27	22.31	17.64	17.91	28.11	20.69
Minority Interest in Earnings	1.53	0.97	0.12	-1.09	-0.88	-0.16
Net Income	16.8	23.28	17.76	16.83	27.24	20.53
Net Income to Common	16.8	23.28	17.76	16.83	27.24	20.53
Net Income Growth	-25.30%	31.07%	5.54%	-38.22%	32.67%	-1.78%
Shares Outstanding (Basic)	20	20	20	20	20	20
Shares Outstanding (Diluted)	20	20	20	20	20	20
Shares Change (YoY)	0.58%	-	-	-	-	0.00%
EPS (Basic)	0.83	1.15	0.87	0.83	1.34	1.01
EPS (Diluted)	0.83	1.15	0.87	0.83	1.34	1.01
EPS Growth	-25.73%	31.07%	5.54%	-38.22%	32.67%	-1.78%
Free Cash Flow	18.36	1.35	33.03	12.96	1.31	7.39
Free Cash Flow Per Share	0.91	0.07	1.63	0.64	0.06	0.36
Gross Margin	68.26%	72.46%	75.96%	73.67%	76.14%	79.60%
Operating Margin	18.67%	25.26%	22.83%	24.90%	32.94%	25.40%
Profit Margin	13.83%	17.88%	14.49%	14.18%	21.38%	17.16%
Free Cash Flow Margin	15.11%	1.04%	26.95%	10.92%	1.03%	6.18%
EBITDA	33.33	41.84	36.84	38.07	48.27	37.13
EBITDA Margin	27.44%	32.13%	30.06%	32.07%	37.88%	31.04%
D&A For EBITDA	10.66	8.95	8.86	8.51	6.3	6.75
EBIT	22.67	32.89	27.98	29.55	41.97	30.37
EBIT Margin	18.67%	25.26%	22.83%	24.90%	32.94%	25.40%
Effective Tax Rate	34.61%	30.11%	25.73%	28.70%	25.25%	22.44%
Revenue as Reported	124.55	133.01	124.82	120.34	128.23	120.99
Advertising Expenses	-	0.2	0.57	0.26	0.12	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.